.
.
.
.

.

) (APIC ) (AVSC
) (WHO )(CDC
).(IFIC

.

.

) (

.


.

)( .

III


. / /
/ .

.
-:
/

) :(2004
/
/
/
/
) :(2005
/
/
/
/
/
IV

 :
:
. /

. /

. /

. /

. /

. /

./

:
. /
:
:
/

/

:
/




" "
  -:
 
/ 
 / 
 / 

 /
 / 
/! 
#$ %! /
) /( '
) /  
, /,
/ 2301
 / %4
) / 34
3
/6
8 / 7,
/ 
9:
3
/ ;
/
%
/$  6
/  >
/! 

VI



    -:

 / 'A
/! %0
/ ,B
 3
/
% -:"#
/
%

%1  %H
 - E0G

3
/ ),9

%1 %H
 - E0 

I 2
/E

%1 %H
 - E0 

) / KH K

%1  %H
 - E0G

M / >'

%1 %H
 - E0 

/
N

%1 %H
 - E0OB%

/ 

%1 %H
 - E0 'KP

/)

%1 %H
 - E0 

'& )-:
/
%

 %)MQ )>


/ ) 

 %)M Q

 .*"#+, -
,!7 / ,
%H /( %H

VII



#1 '- :/
 /G A

# %R %3

 / TS1R

9 2;>9 V 39 

Q%B

 /$ ;1>:1

 W   

/
93

>9
%3$B H %H
 - -E
7 - $

 / 11

 %3$B
K
Q ) (CDC V 39


/ 9

 %3$B
K
Q)(CDC V 39

 / ,17

>9
%3$B H - V 39

/ 9

>9
%3$B H - V 39

 / 

>9
%3$B H - V 39

9 /$

>9
%3$B H  %B1 39


/ 17

] %] V 39

^ /
,

>9
%3$B H   > %

9 /_

>9
%3$B H 

  23+, 2"#(USAID) 2

7 
83 -:2
/ 
K / 
,3

VIII



   2;;  - "#- :(NAMRU-3) 2"#

$ /
W,
/ T
H1M !
/
 /  >G7
)   / KH K H
/ 
/ 3

7 /H
I 3
/ )  ?2+ ># (

IX




" ;'"2
  -:
 / 
 / ,

 /
M / 
/! 
) /( '
/ ,
) /  
/ 
%a
 / %4
) / 34
3
/6
8 / 7,
/ 
9:
3
/ ;
/
%
/$  6
/  >
/! 



)     -:

 C2. 2B+,  -:22,+
.8 / 7,
% -:"#
/
%

%1  %H
 - E0G

/
 , , :

%1 %H
 - E0 

. / c

%1  %H
 - E0G

/
N

%1 %H
 - E0OB%

..,39$ !
/

%1  %H
 - E0G

..2;0
7$ /

%1  %H
 - E0G

. %M$ / K

XI


.........................................................................

22-1

...............................................................................................

.................................

...........................................................

............................................................

) ( ..............................

............................................................

................................................................................

10

)( .....................................................

19

.............................................................

19

.................................................

19

....................................................................

20

...........................................

20

.........................

22

.................................................

22



)(................................................................

42-23

.............................................................................................

23

.....................................................

24

..........................................................

25

...............................................................................

25

.............................................................................................

27

...............................................................................................

29

..................................

30

..............................................................................

33

) ( ..................................................

33

)( ............................................................

35

)( ......................................................

35

.........................................................................

36

........................................................................

57-43

................................................................................................

43

...........................................................

44

..................................................................................

46

......................................................................

46

.........................................................................

58

................................................

54

..................................................................

67-58

................................................................................................

58

)(
) (

)(



..............................................

59

....................................................................

59

.......................................................................

62

.............................................

63

..............................................................................

64

.........................................................................................

66

..........................................

84-68

................................................................................................

68

..............................

69

....................

69

......................

70

..................................................................................

75

.....................................................

78

......................................................

79

................................

80

........................................................................

101-85

................................................................................................

85

..............................................................

89

.........................................

90

........................................................

90

..............................................

94

........................

97



)( ....................................................

113-102

...............................................................................................

102

.....................................................................................

103

)( .................................................

107

...............................................................................

109

.......................................................................................

110

)( ..............................................

111

...........................................................

112

)( ...........................................

112

.............

118-114

...............................................................................................

114

...............................................................

114

.............................................................................

115

..............................................................................

116

...............

117

...............................................

131-119

...............................................................................................

119

....................................................

119

................................................

120

..............................................................................

124

...............................................

125

..........................................................................................

129



..............................................................................

131

...................................................................

139-132

..............................................................................

149-140

 
 

46

46

48

52

68

84

85

90

10

92

11

93

12

) (

94

13

) (

95

14

102

15

117

16

118

76

18- 16
66 65

96 95

98 97

99

104

10

106 105

11

116 115

12

120 119

13

120

14

127


 

)( )(
)(
)(

)(

  )  : (1 

:
.
-:
.

.


.


 

:


.
) (
.


) ( )(





.

:

) : "" ""
"" (
.


.
)(
.


 

:


)( )(
)( .

) ( .

.

:



.

-:
-:
.1 .
.2 .
.3 .
.4 .
.5 .

) (1 :


) (
)(


 

.


,
:
) ( ) .
" " -
(.
:
.
.
.
.
.
.
:

) (2 :

) (

.
:
.1 .


 

.2
.
.3 ) ( .

:


.

.
:

) : (
)(
.

:
.

:
,
.
:
.
.


 

): (Rubber Dam

.

.

.

.

,


.
) :(1

)(
.

.
6


 

)
(.

:

.. .
) : (
.

.
.
.




.

.

.

) : )( (
.
7


 

) (


.
) :(2

)
(

" " (

"
)(.

".

" "
.

.

.

.


 

.
) :(3

.
.

.

.
.
) "
.

" (.

" " "

.

" .

.



.

.

.
.


 

) : (
.

)( .
.

.

) (3

) ( .
:
:

)
"" (.
:



.
:
.

10


 

)
( .

" "

20 30
.


.
.

. .

11


 

.


) " "(

.
.
) ,
(.
.

:



.
)( ) "
"( .
.


.

12


 

) (

.

. :


,
.

.
:

. :
.

13


 

) (
) (
)( .

.

   ! 
:
.

.

.


.

.

. .

.

14


 

) (4


)
(
)

(.
:

500

.

):
(




) "
" - (.
.

15


 

) :(4

Appliances

/
Metal / acrylic
All metal

)(Articulators

)( )
(
Custom impression
) trays( acrylic
) ( Impressions

) (Face bows
)(Casts

16


 

) :(4
*

)( Irreversible
)hydrocolloid (alginate

Reversible hydrocolloid

Polysulfide rubber

30

Silicone rubber
Polyether

ZOE

Impression
compound

17


 

) :(4

) ( Prostheses

)/(
Removable
)(acrylic/porcelain
) /(
Removable
)(metal/acrylic
) /( Fixed
)(metal/porcelain
) (

Shade guides

wax rims

) wax bites

(

.
.

18


 

)(
)
prophylaxis angles prophylaxis cups

brushes

tips for high-speed air evacuator,

saliva ejectors )( , and air/water syringes

.

.


.
)(

)


.

19


 

.
.
) . (

.
:

) :
(
.
:




.

:
.
.

20


 

:


.
:

:
(1 .
(2 .
(3 .
(4
.
(5
.
(6 .
(7
.
(8 .
:

.

21


 

)(

.

) .
" " (.

.
.
.

.

.

.

22


 

)(

)(
)(
)
( ) (


)(
.
.
)( :
) ( ) ( . )(
.

.
)(
.

.
)(
.

23


 

)(
)(

-:
.
.
.
)(
)(
)(
)(
.
)(
) ""
""(.

.
) (.
.
) (

)(


)(

.

)( .
24


 

.

....



.

) (
)(
)( )
(

)
( .
)(
)(
)(

) "
" (.

:

.

:
.

25


 

:
)(

)(

)(.
)(

)(
.

)( )( )( .

.

.
)(
)(

)( .
)(
)(
) (

.

26


 

)( .
.
.

.


)
(.
.
)(

)(
.
.

)( )(
.

)(.

)(
:

)( .
)( :
)( - :

27


 

.1

)( .
.2 :
)(
)(

.3 :
)( .
:

)(


,

)( .

) (
) (
.

:
:

)( .

)( .

28


 

) (
.
)( .

)( .

)(
)(
)( .

) (.

.
:

5000

) 9 : 1 ( %5 .

) (.
29


 

)(


)(

)(
.
)(

63 .1996

.
:

.
)(
.

.
)(
.

)( )( 200
.
2000
.
.

)(
)(
)(
30


 

:
%100 .
.
)( - :
.1 )- :(Carbon filters

.

.

.
.2 )-:(Particulate filters


.
:
.
.3 )): ( Reverse Osmosis (RO
) (

)

31


 

( %99 - %90
.
:
.
.4 ):(Deionizers
) ( ) (resin beds


.
:

) (.
\

.5
)Filters, ultrafilters, and ultraviolet germicidal irradiation (UVGI
)(

.

.

.
)(

.

32


 

:
(1 .
(2 .
(3 .
(4 .
)
( 200
/ CFU .
.

)(
.

.
.

) (

) (
)(
) ( )(

33


 

)(
:

)( )(
.

)(
.

:
) (
)(
)(.

.
)( .

)( .
)( .

.

) (

8
48.

34


 

) (S. aureus .

)(

)(.

)(
)(.

) )(
)( (.

)(

)( ) (HBV
35


 

)
(
.

)( ) (HCV
)
(
.

)( ) (HIV
)
(
.

)(

.

)(
.
. .
36


 

" ".
)(


.

.
)(

"
".

" ".



.

)(
:
)(
)(:
.

)(.
3 )
( )( ) (HBsAg
.

37


 

"
.
) (
)( :
o
.
o
)
(
) (
.
o ) (
"

HBsAg

o ) (
"

HbsAg

) (Anti bodies

.
o ""

HbsAg

)( .HBsAg

)(
.

38


 

""
)
(
" "
.

) )( (

"

.

10.

"" HBsAb

) 10 /(.

.

.

) (
" HBsAg
)
(.
39


 

) (HBsAb -ve
" HbsAg
""



"" .

""
"" )(

)(
""
"" 3
.

:
o 3
.
o
)
( )
(
.

40


 

"":
"" )
(
.
"" )
(
.


)( )(
.

" "

" "

" "
""
"" " "
" " .

HIV


.

3-:

HbsAg ""

HIV

HCV Ab ""

41


 

)(

:
.1 )
VRE " MRSA
(.
.2
.

""
.

)(
)
(.

42

 

.
.
.

.

.

.


.



.
)(
.

43

 

.




.

.
:
) ( .
.
) (
)
(.

44

 

.


.
-:
): (Gram-negative bacilli

) :
) (Pseudomonas aeruginosa

) (Klebsiella spp.

) - ( Enterobacter spp. ) (Serratia marcescens )Salmonella

( spp. "") .(Helicobacter pylori

. . :

)spp.

(Strongyloides

).(Cryptosporidium spp.
: )( .
)(
.

45

 

) (

.

  ) : ( 2 

-:
) / (.
) ( ) (. ) ( ) (. )( ) ( . ) ( . )( . )( .  ) : ( 3
 

- -

46

 

..
.


.

.1


.
.2 .


.
.
.3 ) (

.
.4
.
.

47

 

.5

.
.6
.
.7

.
.8

.
.9 .

  ) : ( 4  "!
"&  "$% 

:






.

:
-1

48

 

.


.


.

.
-2 .

-1 : .
%2
. .

)(
.
.
.

:

.
" "14 .
" "28 .

49

 

.
2
% 45 - 20 .

.
.
.
-2 ) ( :


.

%2
.
.
.
.. %6

.

.

-3 :
.
) ( .
50

 

.
.
.
%35
%0.2 .
.
-4 :
%0.08 . %1

.

) (
.
:
)( .

.
:
.
:
.
.

51

 

.
.1 :

.

.
.2 :

.
.3 :
.

  ): ( 5
*+(  

) ""( .
) ""(
.

52

 

)(

.
) (
) ""(

.

.

)
(
.
.


.

.

.

53

 

)
"" ""
"" ( .


.

.

) )( )(
( .

.

"" .

.

.
.
) :
( .

54

 

:
.
.
)
... ( .

.



) 12-10/( .

.

.



.

.

.

55

 

.

.

) :

( .

:

.
.

.
.

.
.

:
.

56

 

.

.
.
.

:
-1
) " " -
- (
-2
.
-3
)"" -
......(
.
-4 .
-5 )
(
-6 )( .
-7 )
....( )
(

-8 .

57

  


.

.

.

.



.

:
.
.
.
.
.




) (
.
.
)(
58

  


)(
. ) (

.

)
.
.
.
)( .
)( .
.
) (.

] " " " "[


.
:
(
-:
) ""(.
.

.
( -:
59

  


.
)
.......
.
.

:



)( )
( .

.
.
o
o

o

o

.
""

.
"" .

60

  


:
.
)(
.


.
)(
.
) ( )(


.
.
" " .

:
:
45-30

)(.

.
) (

) (.


.

61

  


.


.


.
""
)""(
.

) ""(
.

.
) " " (.

)(
) " "(.

62

  


: 3 2.5 ) 9 7(



.
:
.
.
:
.
.
:


.

o :


.
o :
.

.
63

  


.


.
. .

.

.

)
( .
.

.
.
.

) " "(.

64

  


) :(5
:

""

) (

3 4
.

""
.
48

.

6
.
.

.
.

""

) (

.
) (

65

  


.

.

)
(

.
24 ) (.

.
.

.
24.

:
.


/.

(

66

  


.
.
:


.
:

.
.
.
) (

67





 




.



.

) : (6

.



.
.

. 2001
) (%70
.
.

)(
.

:

: .

68





 




)( .

.

) 50 (%95
.
.
.


.

:
* .
*
"" .
*
.
*


.

69





 




- :

.
.

) (

""


.



.

.1 .
.
.2
.3 /.

70





 




.4 ) , ,
"" , ....(
.
.5 , ,
, ..... .
3-2
.6
.
.7
.
.8 .
.9 "" ,
) (no touch technique .
""
.
.10

.
.11

"" .

.12

.
.13

.1

.2
"" .

71





 




.3

.
.4
.
. .5 ""
.
.6
.

) (
-1 :
.
-2 :
-

.
-
.
-3 :
-

.

. )
(.

14 .
72





 




.


.
.


.


.

.

.

.



.

73





 




.


.
48.

.

.
)( :
.

.


.

.
. .


.

.

74





 




) :
(
:


(
-:
) (.
.
.
.
(
-:
.
)
.......

75





 




:
)(
.
.
-:
o
)( )(
.....
o
o
.
o
.
)( :
o )(

.
.
o )(
.
o )(
.
o )(
)(
.
o

)(

76





 




. )(
)(

)( .

.

.

) : )(
(.


.


.

.

)( .
)( )
.

:
. 1250 )(" " )(CMV
77





 




.
)(" " ) (CMV .

.

.
.
.
.
- :

.
1 2
.
.


.


-:
:

""
.

78





 




.
:
.
.
.

:


.
:

.

:
. .-

. . "". "". - .

79





 




"". "" . :

""
.

.

""
.
""

.
.

.

.

.

:
o .
o .
o
.
80





 




.

.

.
.
.
.
- :
3 . 5 . 9 .

:
. .


.
.
.

81





 




.

.
.

.
.

.

.
.

.
.

.
.

.


.


.

82





 




.


.
) (

:
-

)(
.

.
.
-

) (

:
.
.
.

)( .


.

83





 




)(


.



.

) (7

.
)
(
.



) %70
500 (
)( )
(.

84





)
(

) (8

.%77

.

.
:
-1 :
)( .

) -( .
) (
) (
)(
) " "(
) "" (
) " " (
.

85





-2 : :
) ( ) (
.
"" .



... .

.

,

.

.

:


.

86





) (
.
.

:
:
:
. . - .

:
.
.
.
.
.
.

.
) (

.
-:
:
.
.

87





:


.

.

.
.
.%60-30
24-18


.
) : (

.
.

: 30 :25
.

: .

88





:
) :

(.

.
:
.
:

.
:
.
.
0.3
.%99.97
:

.
.
.
30 : 25 .


.
.
.%60-30
24-18 .

-:

89





.
.
.
.
.


.

:
.
) " " - (

:





.
-1 :

) (9

.
-2 :

.
-3 :
)(
.
, .

90





.
-4 :


.
.

.
-5 :
.
-6 )( : )(
)(
.
.
-7 :


.

.

91





) (10

-1 )
.
(
-2

-3

)
(.

-4

)
(
.

-5
.
.
-6

)(
.
.

92





) (11

-1
.

.
-2
.
.
-3
.

.
-4 .
-5 .

:
: .
.

:
. . . - .

93





.


.

) (12
 ) (

-:
. . . .
5
.
.
. ) ( . .
-

94





) (13
 ) (

) :(6

* - -

.
*

.
* .

) ( .
*
.
*
.

95





) :(6

- ..

.


.

. .
* .
*


.

96





) (
.

.
:

) (.
:
.
.

.
) (
)
) (
(.
):(7 :
-1 ) %90 60 (

"" ) (

.
.
.
.

.
.
.

.
97





.
.

%90-60 .

.

-2 ).(%4

6

.
.

.

.

.
.

-3
) ] [
(
)

.
.

.
98





.

% 7.5 . % 10
2
.
) (.

) :(8 :

)(

.



.

.

.
.

99





) (.
) : / (
( ) (.
)

.
.

.
.

.
:

.

) :
( .
)

(.
:
:
" "
.
.

.

100





.
:

.

.
.

.

) ""(
.
.


) 134 5-3( .

101


   

)(

)(
)
(

)(
.

) (14

.
.



)(
)(
.
""
) ( .

102


   

)
... (
.

)( .

.D.N.A

( ) ( )
)( (
.

)(
.
.
.

)( . :
.
.
103


   

) :(9 :

75 : /
.
.HEPA
75
100/ .

HEPA .
)( )( . :
.
:

)( .

)(

)(

) (

.


.
.


.

104


   

)(
)( )(
)
( .

.

) :(10

)( . )(
:

.
.
)(

.

.
:

.
.

)(

.
105


   

) :( 10

) (
.
:
)(

.
)( .
)(


.


)( .

.

)(


.

106


   

)(
.

.

)(.

.... )( .

.

.


.
)(.

)(.
" " )( ,
- -
.

107


   

.1 :
.
.2 :

.
.3 )( :

) (.

)(
.

) -
...( )(.

:
(1 )(
.

108


   

.
(2 .
)(


.

: )(

.

.

.
.

.
.

.
.

) (
.
.
)(
)( 10000
.
109


   

)( )
" " - (.
:
.

)( .
.
)(

.

)
10000 - 5000
" "- ( .
.

)() . ) " "- (

"
- " " - " ...

) (
)(
:
.1 .
.2 ) (.
110


   

.3
) " " (.

.4 .
.5 .
.6 .

)(
:

)(
:
.1 .

.2
.
.
.3 .
.4 .

)(
)(
)(

: ) (

.

-1 .
111


   

-2
.
-3 .
-4 .
-5
.

.1 .
.2
.3
,


10000 - 5000
.

) (.

)(
)(
)( .
.

)( .
.
)( . .

112


   

)( ) (
-1 )(
.
-2
.
-3 )( .
)( .
-4 )(

.
-5 )(
. )(
.
)( .
-6

.
)(
.
-7 .
-8 )(
.
-9 )( .


)( .
113

"!     

     
 

.





.
:
.

.
.
.

.

.

.

114

"!     

     
 

:

)
... (
.
:

)
" ( .
:

)
" " (
:

)
" "2 (
) :(11
:
/

115

"!     

     
 

)
... (
.
)

(




) .
( .

)
( .

.
) (
.

116

"!     

     
 

)
( .



.


.

)(
.

-1 :

.

-2 :

.

  ) : (15  

-3 :
) ( .

117

"!     

     
 

-4 :

.
-5 :

.

-1 ) (:
.
-2 :

.

-3 :

.
-4 :

)
(
.

  )! : (16 

-5:

118

  
  

:


.

.
.


.


.

:
-

) ( 12

Hepatitis A virus

Salmonella Typhi

119

  
  

Shigella species

Staphylococcus aureus

Streptococcus pyogenes

) ( 13

Campylobacter jejuni

Cryptosporidium parvum

Entamoeba histolytica

Enterohemorrhagic Escherichia coli

Enterotoxigenic Escherichia coli

Giardia lamblia

Non-typhoidal Salmonella

Taenia solium

Vibrio cholerae 01

10

Yersinia enterocolitica

.
:

120

  
  

(1 :
).(Salmonella Typhi ).(Shigella spp. ).(E. Coli SHIGA TOXIN-PRODUCING ).(Hepatitis A virus (2 :
).(Salmonella Typhi ).(Shigella spp. ).(E. Coli SHIGA TOXIN-PRODUCING ).(Hepatitis A virus . (3 :
) (Salmonella Typhi . ) (Shigella spp. . - )(E. Coli SHIGA TOXIN-PRODUCING

.
).(Hepatitis A virus (4
:
, , ,
.
.

.
(5
:

121

  
  

) ( :
. .
.


.


.

:
(1
:
(1 ).(Salmonella Typhi
(2 ).(Shigella spp.
(3 )E. Coli SHIGA TOXIN-

.(PRODUCING
(4 ).(Hepatitis A virus
(5 .
(6 , , ,
.
(7 .
(8
.

122

  
  

:


) (.

.

.

, .
.
, .

:

:
, ,
,
.

Crohns
.
123

  
  

) ( ,
.
: ,

).(Salmonella or Clostridium perfringeus
.

( :
.
.
.
.
.
.


.
( :
-1 :
.
-2


.
-3 :

.
124

  
  

-4 :
)
.(2004
-5 :


.
.
-6 :



.

:
( :
.
) (.
.
) ( .
( :

:
.
.
.
.
125

  
  

( :
.
.

.
.
.
:


.
( :

.
:
. . . . .
.

.
( :
.


. ...
126

  
  

) (14 -:

4 7

4
48

10

) (

2 4

18

10 14

48

8 10

.

15.
( :
:
.
.
127

  
  

.
.
.
.
. .( :

) (.

.

.
( :
:
:
60
.
: 10
3 3 .
.60 .
.
.
:
.

128

  
  

:

.
:
:
.
50
.

.
80

.
.
.
.
.

: :
(1 .
(2 .
(3 .
(4.
(5 : .


.
: :

.
129

  
  

: :

:

.

:


.
130

  
  

:


.

.
:

:
(1 .
(2 & Staphylococcus
Streptococcus
Neomycin Bacitracin
.
(3 .
(4 .
(5 .

131

  

Antiseptics

Antiseptic Hand
Wash


Aseptic Techniques





.
)(

Carriage
.

.
Case

Cellular Immunity

)
(


.

Chemical " "
Sterilisation



Chemoprophylaxis .

132

  

Cleaning


.

) (




.

Cohort .

Colonization .

Commensals

)(
Communicable
Period

Conditional
Pathogens

Contact

.

.

)( .

Contamination .


Conventional .
Pathogens
) (

.

Disinfectants

" "
Dry Heat
Sterilization

133

  

Endogenous Infection )
(


.


Environmental
Cleaning .
)(Housekeeping

Epidemic .

Epidemic Incidence .
Rate


) Epidemiological (
Surveilance.

Epidemiology


Exogenous infection

.
.
) (
Flora
) (
General waste (=non ) hazardous waste .
.

)(

) (
)(
Hemodialysis 6-2 .


Highleveldisinfection
) (HLD




.

134

  

Humoral Immunity .

.
Immunity

Immunocompromised

Incidence

Incidence rate

.
) ( .


.

Incubation period.


Index Case .

Infection )
(
.


Infection control .


Infection reservoir.
:

Instruments and other
items

( )(
)


Intrinsiccontamination .

Isolation
.

135

  

)
:
(
:
Medical waste
)(
)(= hazardous waste
.
: ) (


: )(
.
:

.
:

.
:

.
:

.
:

.
:
)
) ( :
(

Microbial flora of the

skin

.
) ( :



.
.

Microorganisms

)(

.

Minimal infective dose

of a microorganism

136

  

Nosocomial infections
(NI) =Health care
associated HAI .


Occupational exposure
.
).(OSHA


Opportunistic .
Pathogens


Outbreak .

Pathogen

)(

Peritoneal Dialysis
.
.

Prevalence Rate .

Protective Isolation or
Environment
) ( .


Reservoir .


Routine Hand Wash.


Seroconversion .
)(
.

Sharps-disposal
container

137

  

Source Isolation .

.

Source of nosocomial
infections


Sporadic cases .


Standard Precautions
.

Steam
sterilization
)(autoclaving
.

Sterile
.

)

(
Sterile .
Service
)Department (SSD
)

Sterilization(
.
:
)""( :

.
) ( :


.
:
.



Surgical attire )(

.

138

  

)(

) Surgical Scrub( .


Susceptible .


Transmission .
mechanism

.
)(
Virulence
.

Zoonosis

139



1-

APIC, 1996. APIC Infection Control and Applied Epidemiology: Priniciples and
Practice. St. Louis: Mosby-Year Book, Inc.

2-

Archibald LK, 2001. Clinical microbiology in developing countries. Emerg Infect

Dis 7: 302-5.

3-

Association for the Advancement of Medical Instrumentation. American National

Standard: Safe handling and biological decontamination of reusable medical
devices in health care facilities and nonclinical settings. AAMI Publishers.( 1110
Glebe Rd., Suite 220-2003, Arlington, VA, 22201, USA ) March

4-

AVSC, 1999. Module 10: Sterilization and storage. Infection prevention curriculum:
A training course for health care providers and other staff of hospitals and clinics:
Trainers manual. New York: AVSC International, 311-371.

5-

AVSC, 1999. Module 11: High-level disinfection and storage. Infection prevention
curriculum: A training course for health care providers and other staff of hospitals
and clinics: Trainers manual. New York: AVSC International, 373-409.

6-

AVSC, 1999. Module 12: Housekeeping. Infection prevention curriculum: A

training course for health care providers and other staff of hospitals and clinics:
Trainers manual. New York: AVSC International, 411-435.

7-

AVSC, 1999. Module 13: Waste disposal. Infection prevention curriculum: A

training course for health care providers and other staff of hospitals and clinics:
Trainers manual. New York: AVSC International, 437-469.

8-

AVSC, 1999. Module 2: Importance and purpose of infection control. Infection

control curriculum: A training course for health care providers and other staff of
hospitals and clinics: Trainers manual. New York: AVSC International, 27-39.

9-

AVSC, 1999. Module 3: Handwashing and use of gloves. Infection prevention

curriculum: A training course for health care providers and other staff of hospitals
and clinics: Trainers manual. New York: AVSC International, 41-109.

10-

AVSC, 1999. Module 5: Aseptic technique. Infection prevention curriculum: A

training course for health care providers and other staff of hospitals and clinics:
Trainers manual. New York: AVSC International, 153-211.

140



11-

AVSC, 1999. Module 6: Use and disposal of needles and other sharps. Infection
prevention curriculum: A training course for health care providers and other staff of
hospitals and clinics: Trainers manual. New York: AVSC International, 213-233.

12-

AVSC, 1999. Module 7: Introduction to processing of instruments and other items.

Infection prevention curriculum: A training course for health care providers and
other staff of hospitals and clinics: Trainers manual. New York: AVSC
International, 235-257.

13-

AVSC, 1999. Module 8: Decontamination and preparation of chlorine solutions.

Infection prevention curriculum: A training course for health care providers and
other staff of hospitals and clinics: Trainers manual. New York: AVSC
International, 259-287.

14-

AVSC, 1999. Module 9: Cleaning instruments and other items. Infection

prevention curriculum: A training course for health care providers and other staff of
hospitals and clinics: Trainers manual. New York: AVSC International, 289-309.

15-

AVSC, 2000. Handwashing. Infection prevention: A reference booklet for health

care providers. New York: AVSC International, 5-6.

16-

AVSC, 2000. Housekeeping and waste disposal. Infection prevention: A reference

booklet for health care providers. New York: AVSC International, 25-55.

17-

Ayliffe GA, A. Hambraeus, S. Mehtar, 1995. International Federation of Infection

Control (IFIC), Education Programme for Infection Control, Basic Concepts and
Training.

18-

Balraj V, et al, 1990. Sterilization of syringes and needles for immunization

programmes using a pressure cooker. J Trop Med Hyg 93: 119-120.

19-

Barnard H, 2000. Hepatitis C in Egypt, an iatrogenic epidemy. Ned Tijdschr

Geneeskd 144: 2024-5.

20-

Barone MA, et al, 1997. Adaptation and validation of a portable steam sterilizer for
processing intrauterine device insertion instruments and supplies in low-resource
settings. Am J Infect Control 25: 350-6.

21-

Burke S, Madan, I., 1997. Contamination incidents among doctors and mid-wives:
reasons for non-reporting and knowledge of risks. Occup Med 47(6): 357-60.

141



22-

among Recommendations for Preventing Transmission of Infections .1999 ,CDC

Georgia
,Chronic Hemodialysis Patients. MMWR October 5-6, 1999 Atlanta

23-

Calil R, et al, 2001. Reduction in colonization and nosocomial infection by

multiresistant bacteria in a neonatal unit after institution of educational measures
and restriction in the use of cephalosporins. Am J Infect Control 29: 133-8.

24-

Carder CC, 1996. Chapter 99: Prehospital and Emergency Department. Olmsted
RN, ed. APIC Infection Control and Applied Epidemiology: Priniciples and
Practice. St. Louis: Mosby-Year Book, Inc., 99-1 - 99-9.

25-

CDC, 1987. Recommendations for prevention of HIV transmission in health-care

settings. MMWR 36(2S): 1S-18S.

26-

CDC, 1988. Update: Universal precautions for prevention of transmission of

human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens
in health-care settings. MMWR 37: 377-82, 387-8.

27-

CDC, 1996. Guidelines for Isolation Precautions in Hospitals.

28-

CDC, 1999. Exposure to Blood-What health-care workers need to know.

www.cdc.gov/ncidod/hip/Blood/exp_blood.htm.

29-

Recommendations for Preventing Transmission of Infections Among .CDC, 2001

.Hemodialysis Patients. MMWR 2001/50(NO. RR-5):1-43 chronic

30-

CDC, 2001. Updated Guidelines for Evaluating Public Health Surveillance

Systems. Recommendations from the Guidelines Working Group. MMWR.

31-

CDC, 2002. Guidline for Hand Hygiene in Health Care Settings, MMWR October
25,2002/VOL.51/NO.RR-16

32-

CDC, 2002. Staphylococcus aureus resistance to vancomycin- United States,

2000. MMWR 51(26).

142



33-

CDC, 2003. Guidelines for environmental infection control in health-care facilities .

Recommendations of CDC and the Healthcare Infection Control Practices
Advisory Committee (HICPAC).

34-

CDC,2002. Guidelines for the Prevention of Intravascular Catheter-Related

Infections .MMWR August 9, 2002 / 51(RR10);1-26

35-

Checko PJ, 2000. Outbreak Investigation. Pfeiffer AJ, ed. APIC Text of Infection
Control and Epidemiology. Washington, D.C.: APIC, 15-1-15-9.

36-

Damani NN, 1997. Manual of Infection Control Procedures.

37-

Drucker E, Alcabes PG, Marx PA, 2001. The injection century: Massive unsterile
injections and the emergence of human pathogens. Lancet 358: 1989-92.

38-

Ducel G, J. Fabry, N. Lindsay, unpublished communication. Nosocomial Infection,

Control, and Prevention, WHO Practical Guidelines, 2nd edition.

39-

el Gohary A, et al, 1995. High prevalence of hepatitis C virus among urban and
rural population groups in Egypt. Acta Trop 59(2): 155-61.

40-

El Sayed NM, et al, 2000. Epidemic transmission of HIV in renal dialysis centers in
Egypt. J Infect Dis 181: 91-97.

41-

Faris R, Shouman, A., 1994. Study of the knowledge, attitude of Egyptian health
care workers towards occupational HIV infection. J Egypt Public Health Assoc
69(1-2): 115-28.

42-

Frank C, Mohamed, M.K., Strickland, G.T., et al, 2000. The role of parenteral
antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:
887-91.

43-

Garner JS, Favero MS, 1986. CDC Guideline for Handwashing and Hospital
Environmental Control, 1985. Infect Control 7: 231-43.

143



44-

Gaynes R, et al., 2001. Feeding back surveillance data to prevent hospitalacquired infection. Emerg Infect Dis 7: 295-8.

45-

Gharib M, 2001. Brief Hospital Guidelines in Infection Control.

46-

Goldsmith RS, et al, 1989. Occupational exposure to hepatitis B virus in hospital

personnel in Cairo, Egypt. Acta Trop 46 (5-6): 283-90.

47-

Hagen DL, et al, 2001. Infectious waste surveys in a Saudi Arabian hospital: An
important quality improvement tool. Am J Infect Control 29: 198-202.

48-

Hanson PJ, et al, 1991. Recovery of the human immunodeficiency virus from
fibreoptic bronchoscopes. Thorax 46: 410-412.

49-

Harbarth S, et al, 1999. Outbreak of Enterobacter clocae related to understaffing,

overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 20: 598603.

50-

Hart CA, and Kariuki, S., 1998. Antimicrobial resistance in developing countries.
BMJ 317: 647-50.

51-

Horan TC, Emori, T.G., 1997. Definitions of the key terms used in the NNIS
System. Am J Infect Control 25: 112-6.

52-

Horan TC, Emori, T.G., 1998. Definitions of nosocomial infections. Abrutyn E,

Goldmann, D.A., Scheckler, W.E., ed. Saunders Infection Control Reference
Service. Philadelphia: W.B. Saunders, 17-22.

53-

Huskins WC, et al, 1998. Hospital infection prevention and control: a model for
improving the quality of hospital care in low- and middle-income countries. Infect
Control Hosp Epidemiol 19(2): 125-135.

54-

International Society for Infectious Diseases, A Guide to Infection control in the

Hospital, third edition,2004.
James Chin, Control of Communicable Diseases manual, seventeenth edition,
.2000

55-

144



56-

Jarvis WR, 2001. Infection Control and Changing Health-Care Delivery Systems.
Emerg Infect Dis 7.

57-

Khuri-Bulos NA, et al, 1997. Epidemiology of needlestick and sharp injuries at a

university hospital in a developing country: a three year prospective study at the
Jordan University Hospital, 1993-1995. Am J Infect Control 25: 322-9.

58-

Kirkland KB, et al, 1999. The impact of surgical-site infections in the 1990's:
attributable mortality, excess length of hospitalization, and extra costs. Infect
Control Hosp Epidemiol 20: 725-30.

59-

Larson EL, 1996. Chapter 19: Hand Washing and Skin Preparation for Invasive
Procedures. Olmsted RN, ed. APIC Infection Control and Applied Epidemiology:
Priniciples and Practice. St. Louis: Mosby-Year Book, Inc., 19-1 -19-7.

60-

Lawton RM, et al, 2000. Practices to improve antimicrobial use at 47 US hospitals:

the status of the 1997 SHEA/IDSA position paper recommendations. Infect Control
Hosp Epidemiol: 256-9.

61-

Lee TB, et al., 1998. Recommended practices for surveillance. Am J Infect Control
26: 277-88.

62-

Lundstrom T, et al, 2002. Organizational and environmental factors that affect

worker health and safety and patient outcomes. Am J Infect Control 30: 93-106.

63-

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, 1999. Guideline for
Prevention of Surgical Site Infection, 1999. Centers for Disease Control and
Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J
Infect Control 27: 97-132; quiz 133-4; discussion 96.

64-

McNeil SA, et al., 2001. Outbreak of sternal surgical site infections due to
Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect
Dis 33: 317-23.

65-

Medhat A, et al, 2002. Hepatitis C in a community in Upper Egypt: risk factors for
infection. Am J Trop Med Hyg 66: 633-8.

145



66-

Mehtar S, 1992. Hospital Infection Control: Setting up a Cost -Effective

Programme.

67-

Memish ZA, et al., 2002. Epidemiology of needlestick and sharps injuries in a

tertiary care center in Saudi Arabia. Am J Infect Control 30: 234-41.

68-

Mercier C, 1994. Reducing the incidence of sharps injuries. Br J Nurs 3(17): 8978, 900-1.

69-

Michael Richards, et al ,Epidemiology,prevalence,and Sites of infections in

Intensive Care Unites ,Semin Respir Crit CareMed 24.2003 .22-3 :(1)

70-

Moolenaar RL, et al., 2000. A prolonged outbreak of Pseudomonas aeruginosa in

a neonatal intensive care unit: did staff fingernails play a role in disease
transmission? Infect Control Hosp Epidemiol 21: 80-85.

71-

NIOSH, 1998. Sharps Disposal Containers Part II: Sharps Disposal Containers.

72-

NIOSH, 1999. Preventing Needlestick Injuries in Health Care Settings.

73-

OSHA, 1997. Safer needle devices: protecting health care workers. Washington
D.C.: U.S. Dept of Labor.

74-

Parker M, 1978. Hospital Acquired Infections: Guidelines to Laboratory Methods.

Copenhagen: WHO Regional Office for Europe.

75-

Passaro DJ, et al., 1997. Postoperative Serratia marcescens wound infections

traced to an out-of-hospital source. J Infect Dis 175: 992-5.

76-

PATH, 2000. Giving Safe Injections Training Manual.

146



77-

Quick RE, et al, 2002. Diarrhea prevention through household-level water

disinfection and safe storage in Zambia. Am J Trop Med Hyg 66: 584-9.

78-

Rampling A, et al, 2001. Evidence that hospital hygiene is important in the control
of methicillin-resistant Staphylococcus aureus. J Hosp Infect 49(2): 109.

79-

Rhinehart E, et al, 1991. Adaptation of the Centers for Disease Control guidelines
for the prevention of nosocomial infection in a pediatric intensive care unit in
Jakarta, Indonesia. Am J Med 91 (3B): 213S-220S.

80-

Rutala WA, 1996. Appendix D: APIC guideline for selection and use of
disinfectants. Olmsted RN, ed. APIC Infection Control and Applied Epidemiology:
Priniciples and Practice. St. Louis: Mosby-Year Book, Inc., D-1 - D-17.

81-

Rutala WA, 1996. Chapter 15: General information on cleaning, disinfection, and
sterilization. Olmsted RN, ed. APIC Infection Control and Applied Epidemiology:
Principles and Practice. St. Louis: Mosby-Year Book, Inc., 15-1 - 15-17.

82-

Rutala WA, Weber, D.J., 1995. FDA labeling requirements for disinfection of
endoscopes: a counterpoint. Infect Control Hosp Epidemiol 16: 231-5.

83-

Saez-Llorens X, et al., 2000. Impact of an antibiotic restriction policy on hospital

expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a
developing country. Pediatr Infect Dis J 19(3): 200-6.

84-

Scheckler WE, Brimhall, D., Buck, A.S., et al, 1998. Requirements for
infrastructure and essential activities of infection pcontrol and epidemiology in
hospitals: a consensus panel report. Am J Infect Control 26: 47-60.

85-

Shlaes DM, et al, 1997. Society for Healthcare Epidemiology of America and
Infectious Diseases Society of America Joint Committee on the Prevention of
Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance
in hospitals. Infect Control Hosp Epidemiol 18: 275-91.

86-

SIGN, 2001. Best Infection Control Practices for Skin Piercing Intradermal,
Subcutaneous, and Intramuscular Needle Injections: World Health Organization
(WHO), Safe Injection Global Network (SIGN), International Council of Nurses
(ICN).

147



87-

Skilton R, 1997. Decontamination procedures for medical equipment. Update in

Anaesthesia: 1.

88-

Talaat M, et al,. Occupational Exposure to Needlestick Injuries and Hepatitis B

Vaccination Coverage among Health Care Workers in Egypt.. American Journal in
Infection Control (In press)

89-

The Higher Councel of Public Health in France.100 Recommendations forthe

Surviellance and the Prevention of Nosocomial Infection. 1997

90-

Tietjen L, Bossemeyer, D, McIntosh N. Infection prevention: Guidelines for

healthcare facilities with limited resources. JHPIEGO. (JHPIEGO Corporation,
Brown's Wharf, 1615 Thames Street, Baltimore, MD , 21231 , USA ) 2003.

91-

unpublished communication. Infection Control Policies and Procedures Manual.

92-

Vesley D, et al, 1992. Significant factors in the disinfection and sterilization of

flexible endoscopes. Am J Infect Control 20: 291-300.

93-

Wakefield DS, et al, 1988. Cost of nosocomial infection: relative contributions of

laboratory, antibiotic, and per diem cost in serious Staphylococcus aureus
infections. Am J Infect Control 16: 185-92.

94-

Weinstein RA, 2001. Controlling antimicrobial resistance in hospitals: infection

control and the use of antibiotics. Emerg Infect Dis 7.

95-

Wenzel R, 1995. The economics of nosocomial infection. J Hosp Infect 31: 79-87.

96-

WHO, 1998. Guidelines for Medical Waste Disposal in Hospitals, Labs, and
Primary Health Care Units.

97-

WHO, 2000. Aide-memoire Fact Sheet No.2.

98-

WHO, 2000. Guidelines for the collection of clinical specimens during field
investigation of outbreaks
WHO, 2000. WHO Information Fact Sheet No. 253: Wastes from Health Care
Activities. Geneva: World Health Organization.

99-

100- WHO, 2001. Best infection control practices for skin piercing intradermal,
subcutaneous, and intramuscular needle infections.: WHO/BCT/DCT.

148



101- WHO, 2002. Prevention of hospital-acquired infections. A practical guide, 2nd

edition.
102- WHO, 2006, WHO Guidelines on hand hygiene in health care 2005-2006
103- Wright J, et al, 2002. Expanding the infection control team: Development of the
Infection Control liaison position for the neonatal intensive care unit. Am J Infect
Control 30: 174-8.
104- 1999. Waste Management in Cairo, Giza, Sharkia, and Gharbia. Cairo: Ministry of
Health and Population.
105- 2001. Review of Hospital Isolation and Infection Control Precautions. UK: Joint
Working Group, Table 8, page 42.
106- %*) '&+# ,-  $/ 0 - "!   #$  

149